Group 1 - Stone Fox Capital is a Registered Investment Advisor (RIA) based in Oklahoma, led by Mark Holder, a CPA with extensive experience in accounting and finance [1] - Mark Holder has 30 years of investing experience, including 15 years as a portfolio manager, and leads the investing group Out Fox The Street [1] - The investing group provides stock picks, deep research, model portfolios, daily updates, real-time alerts, and community chat for readers [1] Group 2 - The article does not contain any specific investment recommendations or solicitations to buy or sell securities [2][3] - It emphasizes the importance of conducting personal research or consulting a financial advisor before making investment decisions [3]

Group 1 - Stone Fox Capital is a Registered Investment Advisor (RIA) based in Oklahoma, led by Mark Holder, a CPA with 30 years of investing experience, including 15 years as a portfolio manager [1] - Mark Holder leads the investing group Out Fox The Street, which provides stock picks and in-depth research aimed at identifying potential multibaggers while managing portfolio risk through diversification [1] - The features of Out Fox The Street include various model portfolios, stock picks with identifiable catalysts, daily updates, real-time alerts, and access to community chat and direct communication with Mark for inquiries [1]

Does the ~45% correction in Hims & Hers Health ( HIMS ) open up a great opportunity for investors who missed the 2024-25 rally? My view is that it does. The markets have come down heavilyI am a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management. My focus is on equity valuation, market trends, and portfolio optimization to uncover high-growth investment opportunities. As a former Vice President at Barclays, I led teams in model validation, stress ...

Core Viewpoint - The approximately 45% correction in Hims & Hers Health (HIMS) presents a potential investment opportunity for those who missed the rally in 2024-25 [1] Group 1: Market Analysis - The markets have experienced a significant downturn, which may create favorable conditions for investors [1] Group 2: Analyst Background - The analysis is conducted by a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management [1] - The analyst has a strong focus on equity valuation, market trends, and portfolio optimization to identify high-growth investment opportunities [1] - Previous experience includes a role as Vice President at Barclays, leading teams in model validation, stress testing, and regulatory finance [1] Group 3: Research Approach - The research approach combines rigorous risk management with a long-term perspective on value creation [1] - There is a particular interest in macroeconomic trends, corporate earnings, and financial statement analysis to provide actionable investment ideas [1]

I am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge, I hope to provide other investors with a contrasting view of my portfolio, given my particular background.If you have any questions, feel free to reach out to me via a direct message on Seeking Alpha or leave a comment on one of my articles.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the ...

Group 1 - The focus is on growth and dividend income as a strategy for retirement planning [1] - The portfolio is structured to generate monthly dividend income that grows through reinvestment and annual increases [1] Group 2 - The article emphasizes the importance of conducting personal research before making investment decisions [2] - It clarifies that the opinions expressed are personal and not intended as specific investment advice [2][3]

Since my last rating , Hims & Hers Health Inc. ( HIMS ) shares are down 30% while the market is up 5%. Not a great result.Hi! I'm a passionate investor who has been researching publically traded companies for over 6 years. My primary focus is on identifying great businesses at reasonable prices and holding them for the long term but I also dive into trend following strategies from time to time. While I have a slight bias toward technology companies, I maintain a broad perspective, including opportunities in ...

Group 1 - Hims & Hers Health Inc. (HIMS) shares have decreased by 30% since the last rating, while the market has increased by 5%, indicating underperformance [1] - The company is focused on providing health and wellness products, but recent stock performance raises concerns about its market position [1] Group 2 - The analyst has a beneficial long position in HIMS shares, indicating confidence in the company's potential despite recent stock declines [2] - The analysis reflects a broader investment strategy that includes technology and crypto opportunities, suggesting a diverse approach to market trends [2]

Key Takeaways HIMS leverages AI and data to personalize care, refine treatments, and scale its healthcare platform.Hims & Hers' recent launches include Labs for biomarker tracking and smarter, doctor-developed care plans.HIMS boosts its MedMatch and AI workflows to enhance diagnosis, personalization, and care quality.The renowned health and wellness platform, Hims & Hers Health, Inc. (HIMS) , positions data and AI as central to building a more personalized, scalable healthcare experience, where every custom ...

Market Sentiment - The stock market mood at the beginning of 2026 is characterized by nervousness among investors [1] - There is skepticism regarding the ability of large-cap growth stocks to maintain high valuation premiums amid soft macroeconomic conditions [1] Analyst Background - Gary Alexander has extensive experience in covering technology companies on Wall Street and working in Silicon Valley [1] - He has served as an adviser to several seed-round startups and has been a contributor on Seeking Alpha since 2017 [1] - His insights are widely disseminated, being quoted in various web publications and featured on trading apps like Robinhood [1]